Breaking News

inVentiv Health Names Clinical Ops EVP

December 18, 2012

Stansfield to lead development in Europe, Asia-Pac, and Latin America

Dr. Susan C. Stansfield has joined PharmaNet/i3, inVentiv Health’s clinical segment, as executive vice president of Clinical Operations for Phase II-IV Development in Europe, Middle East, and Africa (EMEA), Asia-Pacific, and Latin America. 
 
Dr. Stansfield has successfully held senior leadership positions at other global clinical research organizations and has a proven record of significantly enhancing clinical operations.
 
“This appointment demonstrates PharmaNet/i3’s commitment to enhancing support for regional operations in parallel to our global cross-functional project management team,” said Dr. Robert M. Reekie, chief operating officer, Phase II-IV Development. “We believe Susan is a great addition to our talented global team that is focused on delivering the best possible service to our clients.”
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision